⌘K

Home/Filings/4/0001209191-21-046026

4//SEC Filing

Fountain Nathan B 4

Accession 0001209191-21-046026

CIK 0001576885other

View on SEC.gov Company Profile

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 6:13 PM ET

Size

4.5 KB

Accession

0001209191-21-046026

Insider Transaction Report

Form 4

Period: 2021-07-06

Acumen Pharmaceuticals, Inc.ABOS

Fountain Nathan B

Director

Transactions

Purchase
Common Stock
2021-07-06$16.00/sh+6,250$100,000→ 6,250 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Acumen Pharmaceuticals, Inc.

CIK 0001576885

Entity typeother

Related Parties

1

filerCIK 0001869596

Filing Metadata

Form type: 4
Filed: Jul 7, 8:00 PM ET
Accepted: Jul 8, 6:13 PM ET
Size: 4.5 KB

View on SEC.gov